Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
When would you recommend postmastectomy radiation to a male, status post mastectomy with 1/1 sentinel nodes with ITCs?
Answer from: Radiation Oncologist at Community Practice
Upfront ITC is not an indication for PMRT unless indicated for T factor. ITC after chemo, would treat like node-positive with PMRT.
Sign in or Register to read more
Answer from: Radiation Oncologist at Community Practice
If T1-T2 with ITCs, I would not recommend PMRT. If T3 with ITCs, I would discuss the pros/cons and favor if ER-. If T4, I would recommend.
Comments
Radiation Oncologist at Radiation Oncology Associates P.C.
Would the presence of ITCs in multiple sentinel no...
Radiation Oncologist at Allegheny Health Network, Pittsburgh
It would not. As Dr. @Sushil Beriwal noted, i...
Radiation Oncologist at Radiation Oncology Associates P.C.
Thank you.
3872
3877
3887
Sign in or Register to read more
Answer from: Radiation Oncologist at Community Practice
For those seeking reference data on the above question, here are a couple: Karam et al., PMID 24035330 Mittendorf et al., PMID 25488970
Sign in or Register to read more
9093
9088
10713
Related Questions
In a patient with cardiac comorbidities, who meets ASTRO APBI criteria other than a positive margin, would you offer APBI in an attempt to reduce cardiac dose?
In cT4aN0 triple negative breast cancer would you still recommend PMRT if pCR, ypT0N0(sn), after neoadj chemo is achieved?
In patients with HER-2 positive breast cancer on pertuzumab/trastuzumab with newly developed asymptomatic brain metastases only, do you wait 3 weeks after administration of the targeted therapy to deliver SRS?
Would you recommend PMRT to a clinically node positive (biopsy proven axillary node and indeterminate single IMN node) BRCA positive patient with multiple medical co-morbidities including scleroderma and ILD who is treated with neoadjuvant chemotherapy (NAC) and mastectomy who converts to ypT0/ypN0?
Do you recommend self-breast exams to your patients with history of breast cancer in addition to imaging surveillance?
Is there any increased risk with adjuvant breast radiation for a patient with muscular dystrophy?
When should the dissected axilla (levels I-II) be included when delivering RNI?
Do you consider chest wall constraints when treating with 5-fraction APBI?
Would you offer APBI to a patient with very large breast anatomy and a small lumpectomy cavity after an oncoplastic closure?
What is your preferred sequencing of adjuvant chemotherapy and PMRT for node + breast cancer?